Skip to main content
Contact Us
Subscribe
E-Edition
59°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Pharmaceuticals SPDR
(NY:
XPH
)
46.57
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,761
Open
46.57
Bid (Size)
44.96 (2)
Ask (Size)
46.44 (2)
Prev. Close
46.57
Today's Range
46.57 - 46.57
52wk Range
36.49 - 48.76
Shares Outstanding
35,502
Dividend Yield
1.67%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
July 26, 2024
AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.
Via
MarketBeat
Topics
ETFs
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
June 27, 2024
The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,...
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Performance
YTD
+11.73%
+11.73%
1 Month
+1.97%
+1.97%
3 Month
+4.60%
+4.60%
6 Month
+15.56%
+15.56%
1 Year
+26.24%
+26.24%
More News
Read More
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Via
Talk Markets
Topics
ETFs
Organon Beats On Q1, Women's Health Leads the Charge
May 02, 2024
Via
Benzinga
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
Via
Talk Markets
Topics
ETFs
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
Via
Benzinga
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Via
Talk Markets
Topics
ETFs
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Via
Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Via
Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Via
Talk Markets
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
Via
Talk Markets
3 Pharma Stocks Yielding Over 3%
January 18, 2022
Via
Talk Markets
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Via
InvestorPlace
The Bear Market Is Already Here – But Not For Dividend Investors
December 22, 2021
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
Via
Talk Markets
The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour
August 20, 2021
Via
Talk Markets
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
The 2 Best Pharma Stocks to Buy on Dips
June 23, 2021
Via
Talk Markets
Exposures
COVID-19
3 Top Pharma Stocks to Buy This Month
June 09, 2021
Via
Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
May 12, 2021
Via
Talk Markets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
